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Evolution involves not only adaptation, but also the degradation of superﬂuous features.
Many examples of degradation at the morphological level are known (vestigial organs, for
instance). However, the impact of degradation on molecular evolution has been rarely
addressed. Thioredoxins serve as general oxidoreductases in all cells. Here, we report
extensive mutational analyses on the folding of modern and resurrected ancestral bacter-
ial thioredoxins. Contrary to claims from recent literature, in vitro folding rates in the thior-
edoxin family are not evolutionarily conserved, but span at least a ∼100-fold range.
Furthermore, modern thioredoxin folding is often substantially slower than ancestral thior-
edoxin folding. Unassisted folding, as probed in vitro, thus emerges as an ancestral ves-
tigial feature that underwent degradation, plausibly upon the evolutionary emergence of
efﬁcient cellular folding assistance. More generally, our results provide evidence that deg-
radation of ancestral features shapes, not only morphological evolution, but also the evo-
lution of individual proteins.
Introduction
Instances of so-called imperfect (poor or suboptimal) ‘design’ have been extensively studied in
records of evolutionary history, and have served as evidence that living organisms, rather than being
designed, are the products of complex evolutionary forces and histories [1,2]. Glaringly questionable
‘design’, such as the recurrent laryngeal nerve in mammals, thus suggests that evolutionary tinkering
with previously functional features can limit the possible outcomes of new functions in the future.
Still, many examples of imperfect morphological ‘design’ are simply related to the evolutionary deg-
radation of ancestral features that are no longer useful. Examples are abundant and include human’s
limited capability to move the ears (linked to the degradation of barely used muscles) as well as the
presence of a tailbone, vestigial leg bones in whales and vestigial wings in ﬂightless birds. Evolutionary
degradation is primarily a consequence of the inability of natural selection to purge mutations that
impair a feature, once the feature has ceased to be useful (i.e. once it has ceased to confer a functional
selective advantage). Darwin did realize that ‘rudiments’ are evidence of descent from ancestral forms
and discussed many examples in the ﬁrst chapter of The Descent of Man (1871). More recently, the
discovery that genomes include large numbers of pseudogenes has provided a clear example of evolu-
tionary degradation at the molecular level. Thus, reversing the mutations that originally led to the
silencing of a given gene does not typically restore the function of the encoded protein [3] because,
after a gene is silenced, it is no longer subject to purifying natural selection and quickly accumulates
other degrading mutations.
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Plausibly, the evolutionary degradation of useless ancestral features is widespread, not only in morphological
evolution, but also during the course of molecular evolution. Other than pseudogenes [3], however, molecular
examples appear to have been rarely discussed in the literature, if at all. We argue here that evolutionary analysis
of protein folding processes may provide clear examples of evolutionary degradation at the molecular level. This
is so because folding in vivo within modern organisms [4–9] is protected and assisted by a complex
folding-assistance machinery, including chaperones and the chaperone functionality of the ribosome, while, on
the other hand, folding studies in the test tube (in vitro folding) probe unassisted folding. Since evolution has no
foresight, however, folding assistance cannot have arisen before protein folding itself, inasmuch as the components
of the folding-assistance machinery are proteins themselves that need to be folded to be functional. It follows that
the most ancient proteins could plausibly fold with little or no assistance. Therefore, unassisted folding may have
been relevant at a primordial stage, prior to (or concomitantly with) the emergence of folding assistance.
We propose, therefore, that the in vitro folding process for modern proteins of ancient evolutionary origin may
bear signatures of evolutionary degradation. Thioredoxins, general oxidoreductases that display a wide substrate
scope and that are involved in a diversity of cellular processes [10,11], should provide an excellent model system
to explore this possibility. They are present in all known cells (eukaryotes, bacteria and archaea) and it is thus
plausible that they existed at a very early stage, even perhaps preceding the emergence of an efﬁcient folding
assistance. Indeed, thioredoxins can fold without assistance in the test tube. It has been known for many years
[12], however, that thioredoxins have a ‘folding problem’ related to the presence of a proline residue in cis con-
formation at position 76 (we use Escherichia coli thioredoxin numbering throughout). Cis-prolines in native
protein structures create folding kinetic bottlenecks [13–15], since isomerization is slow, the trans conformer is
favoured in unfolded polypeptide chains and may become trapped in intermediate states in the folding landscape
thus further slowing down folding. For thioredoxins, mutational escape from the problem is not possible, since
position 76 is close to the catalytic disulﬁde bridge and the presence of a proline at that position is required for a
fully functional active-site conformation [12]. Pro76 is thus strictly conserved in thioredoxins.
Here, we ﬁrst study the folding in vitro of E. coli thioredoxin and two of its resurrected Precambrian ances-
tors. An extensive mutational analysis allows us to explain the slower folding of the modern protein in terms of
a single amino acid replacement that aggravated the folding problem created by the cis-proline at the active
site. Furthermore, the identiﬁed replacement points to a region of the thioredoxin molecule where mutations
can be reasonably expected to impact the folding rate. Experimental analysis of a set of modern bacterial thiore-
doxins selected to represent natural sequence diversity in this region shows that, contrary to what it has been
claimed in recent literature [16,17], in vitro folding rates are not evolutionarily conserved. In fact, in vitro
folding for some of the studied modern thioredoxins occurs in the approximately hour time scale and is
between 1 and 2 orders of magnitude slower than both the inferred ancestral folding and the folding of other
modern thioredoxins. These results suggest an interpretation of in vitro folding as a degraded version of prim-
ordial unassisted folding. More generally, our results provide evidence that degradation shapes evolution not
only at the morphological level but also at the level of individual enzymes.
Materials and methods
Protein expression and puriﬁcation
E. coli, LBCA and LPBCA thioredoxins as its variants studied in this work were prepared without puriﬁcation
tags following procedures we have previously described in detail [18–20]. Proteins representing bacterial thiore-
doxins (Figure 6) were prepared with His-tags using afﬁnity chromatography. Mutations were introduced using
the QuikChange Lighting Site-Directed Mutagenesis kit (Agilent Technologies) and checked by DNA
sequencing.
Protein solutions were prepared by exhaustive dialysis at 4°C against 50 mM Hepes (pH 7). Protein concen-
trations were determined spectrophotometrically using known values for the extinction coefﬁcients. Solutions
of guanidine in 50 mM Hepes (pH 7) were prepared as previously described [18–20]. Prior to use, urea was
puriﬁed by ion-exchange chromatography as previously described [21]. Guanidine and urea concentrations
were determined by refractometry.
Activity determinations
Most reported activity determinations are based on the insulin turbidimetric assay [22], as described previously [18].
Brieﬂy, thioredoxin catalysis of the reduction in insulin by DTT is determined by following the aggregation of
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the β-chain of insulin. An aliquot of a thioredoxin solution is added to 0.5 mg/ml of bovine pancreatic insulin
and 1 mM DTT at pH 6.5 and the rate is calculated from the slope of a plot of absorbance versus time at the
inﬂexion point (see Supplementary Figure S1 for illustrative examples). Values given (Figure 3c and
Supplementary Table S1) are the average of at least three independent measurements.
For some selected variants, we also assayed thioredoxin activity with thioredoxin reductase coupled to the
reduction in Ellman’s reagent (5,50-dithiobis(2-nitrobenzoic acid) or DTNB) at pH 8, essentially as described
by Slaby and Holmgren [23]. Concentrations used were 0.02 μM for the reductase, 0.5 mM DTNB and
0.25 mM NADPH. Thioredoxin concentrations were typically in the range 0.15–0.20 μM. Values reported are
the average of at least three independent determinations.
Unfolding and folding kinetics studied by steady-state ﬂuorescence
measurements
Kinetic data for non-mutated E. coli thioredoxin and LPBCA thioredoxin given in Figures 3, 4 and
Supplementary Figure S10 are taken from [20]. All other kinetic data shown were obtained in this work. All
experiments were performed at 25°C. Folding–unfolding kinetics were studied using procedures we have previ-
ously described in detail [20,24]. Brieﬂy, we measured the time-dependence of the ﬂuorescence emission at
350 nm with excitation at 276 nm, after suitable guanidine- or urea-concentration jumps. For experiments in
guanidine solutions, we typically used 20-fold dilution from ∼4 to 5 M guanidine or from zero guanidine con-
centration for experiments carried at denaturant concentrations approximately above or below the denaturation
midpoint. For experiments in urea solutions, we typically used 20-fold dilution from ∼10 M urea or from zero
urea concentration for experiments carried at denaturant concentrations approximately above or below the
denaturation midpoint. The ancestral LBCA and LPBCA thioredoxins are highly stable and are not fully dena-
tured despite high concentrations of urea. Folding rates for these proteins in urea solutions (Figure 6) were
obtained by ﬁrst denaturing them in concentrated guanidine followed by a high dilution into urea solutions, in
such a way that the ﬁnal guanidine concentration was very low (∼0.1 M). Typically, the protein concentration
in the ﬂuorescence kinetic experiments was on the order of 0.05 mg/ml.
Unfolding kinetics could be adequately ﬁtted with a single exponential equation from which the rate constant
could be easily calculated (see Supplementary Figure S2 for representative examples). Many folding proﬁles
could also be well described by a single exponential within the time range of the manual mixing experiments.
However, two exponential terms were required to achieve good ﬁts in many other cases (see Supplementary
Figure S3 for representative examples).
Finally, the long-time, equilibrium ﬂuorescence values derived from the analyses of kinetic proﬁles were used
to assess the thermodynamic stability of the modern thioredoxins studied in this work. Proﬁles of equilibrium
ﬂuorescence intensity versus urea concentration were ﬁtted assuming a linear dependence of the unfolding free
energy with denaturant concentration [25] within the narrow transition range and using linear pre- and post-
transition baselines. Values of the urea midpoint concentration (C1/2, the urea concentration at which the
unfolding free energy is zero) and the denaturant-concentration dependence of the unfolding free energy (m =
−dΔG/d[urea]) were obtained from the ﬁts. These values are collected in Supplementary Table S4, where add-
itional details of the ﬁtting process are provided.
Using double-jump unfolding assays to determine the relevant kinetic phase
of the major folding channel
Unlike unfolding, which often occurs in a single kinetic phase, protein folding is typically a complex process
involving several parallel kinetic channels leading to the native state, as well as the transient population of inter-
mediate states in many of these channels [26]. In vitro folding of thioredoxin is certainly known to conform to
this scenario [27]. In this work, the complexity of in vitro thioredoxin folding is revealed by the multi-
exponential folding proﬁles found in some cases (Supplementary Figure S3) and by clear rollovers in the
folding branches of all the Chevron plots reported (Figures 3, 4, 6 and Supplementary Figure S10). In general,
the folding rate of any given protein (i.e. the rate that deﬁnes the time scale of the protein folding process)
could be deﬁned in terms of the main slow phase of an experimental folding kinetic proﬁle obtained using a
suitable physical property. Still, it is absolutely essential to ascertain that this phase does indeed reﬂect the
major kinetic channel that leads to the native protein. It would be conceivable, for instance, that most of the
protein arrived to the native state in a slower phase that does not bring about a signiﬁcant change in the
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physical property being measured (steady-state ﬂuorescence, in our case) and which is, therefore, not detected.
Also, it would be conceivable that most of the protein arrives to the native state in a fast phase and that the
slower phase detected in the kinetic folding proﬁles reﬂects a minor structural re-arrangement of the native
ensemble or, alternatively, the folding of a small fraction of the protein from a kinetically trapped intermediate
state. Thus, even if a single exponential phase is detected by the physical property used, there is the possibility
that folding actually occurred during the dead time of the kinetic experiment. Furthermore, a very slow phase
of small amplitude could just reﬂect instrumental drift. These and other interpretation uncertainties plagued
the in vitro protein folding ﬁeld since its beginnings. However, pioneers of the ﬁeld found reliable ways around
these problems on the basis of carefully designed ‘jump assays’ in which protein samples are extracted at
certain times and transferred to solutions of selected composition for experimental assessment (see, for instance
[13,14]). Here, we have speciﬁcally used double-jump unfolding assays, a methodology that aims at providing a
direct determination of the amount of native protein [28,29]. The rationale behind this approach is that the
unfolding of the native state of a protein is much slower than the unfolding of non-native or intermediate
states. The amount of native state in a protein solution can then be determined from the unfolding kinetics fol-
lowed in the appropriate time scale after transfer to denaturing conditions. Obviously, unfolding assays exploit
the high activation free energy barrier for unfolding to determine the amount of native protein, i.e. they exploit
the free energy barrier that confers kinetic stability to the native protein [30,31]. They are, therefore, particu-
larly appropriate for this work because following folding kinetics using double-jump unfolding assays does
deﬁne the time scale required for the development of kinetic stabilization. That is, they deﬁne the time span in
which the unassisted folding chain is susceptible to undesirable interactions and alterations, which is a param-
eter of direct evolutionary signiﬁcance.
For most the thioredoxin variants studied here, we have followed the folding kinetics under selected condi-
tions by carrying out unfolding assays at different times after transfer of a denatured protein to native condi-
tions, in such a way that folding kinetic proﬁles of the amount of native state versus time are obtained. In a
typical experiment (see Supplementary Figure S4 for a representative example), we used a concentrated solution
of unfolded protein in ∼4 M guanidine (E. coli thioredoxin and its variants) or ∼5 M guanidine (LBCA thiore-
doxin, LPBCA thioredoxin and their variants) and we started the folding process by a suitable dilution (within
the 2–10-fold range) into a low-concentration guanidine solution to reach a ﬁnal protein concentration on the
order of 1 mg/ml. At given times, aliquots were extracted and transferred (20-fold dilution) to ∼3 M guanidine
for E. coli thioredoxin and its variants or to ∼5 M guanidine for the ancestral thioredoxins and their variants,
and the unfolding kinetics were determined by ﬂuorescence. The fraction of native state (XN) versus time (t)
proﬁle for folding at low denaturant concentration is easily obtained from the amplitude of the unfolding
kinetic phase using a suitable control experiment (Supplementary Figure S4). Supplementary Figure S5 shows
several representative examples of XN versus t proﬁles that illustrate the strong effect of the S/G exchange at
position 74 on the folding rate. In all cases, these proﬁles could be well described by single exponentials, with
initial time and long-time values close to zero and unity. This indicates that these proﬁles probe the relevant
kinetic phase of the major folding channel. Of course, it cannot be ruled out that, in several cases, small
amounts of protein reach the native state through faster or slower channels, since the initial time and long-time
values of the proﬁles actually differ somewhat from zero and unity (see also Figure 6b).
Comparison of the folding proﬁles from double-jump assays (XN versus t) with those obtained using
steady-state ﬂuorescence revealed three different scenarios: (1) ﬂuorescence proﬁles could be well ﬁtted by a
single exponential and the rate constant derived from such ﬁts agreed with the value obtained from the XN
versus t proﬁles (see Supplementary Figure S6 for an illustrative example). (2) Two exponentials were required
to ﬁt the ﬂuorescence folding proﬁles and it was the rate constant from the faster, larger amplitude phase that
agreed with the value obtained from the XN versus t proﬁles (see Supplementary Figure S7 for an illustrative
example). (3) Two exponentials of roughly similar amplitude were required to ﬁt the ﬂuorescence folding pro-
ﬁles and it was the rate constant from the slower phase that agreed with the value obtained from the XN versus
t proﬁles (see Supplementary Figure S8 for an illustrative example).
Finally, it is important to note that following folding kinetics through double-jump unfolding assays is con-
siderably time consuming. Therefore, our approach has been to carry out extensive folding kinetic studies on
the basis of steady-state ﬂuorescence measurements and to determine only a limited number of double-jump
XN versus t proﬁles in order to identify in the ﬂuorescence proﬁles the relevant kinetic phase of the
major folding channel. For the sake of simplicity and clarity, folding branches of the chevron plots given in
Figures 3–5 and Supplementary Figure S10 show only the rate constants for such relevant kinetic phase and do
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not differentiate between data derived from ﬂuorescence proﬁles and data derived from double-jump XN versus
t proﬁles. However, in Supplementary Figure S9 we provide Chevron plots that include the comparison
between rate constants values derived from ﬂuorescence proﬁles and from double-jump XN versus t proﬁles.
Also, Figure 6b shows proﬁles of folding followed by double-jump unfolding assays for several modern bacterial
thioredoxins.
Results and discussion
Modern versus ancestral thioredoxin folding
We ﬁrst compared the folding of modern E. coli thioredoxin with that of two of its resurrected Precambrian
ancestors (Figure 1a): the thioredoxins encoded by the reconstructed sequences for the last bacterial common
ancestor (LBCA thioredoxin) and the last common ancestor of the cyanobacterial, deinococcus and thermus
groups (LPBCA thioredoxin). These two phylogenetic nodes correspond to organisms that existed ∼4 and 2.5
billion years ago, respectively [18,32,33]. We have previously characterized LPBCA and LBCA thioredoxins, as
well as several other resurrected Precambrian thioredoxins, in detail [18–20,33–35]. They are properly folded,
highly stable, active enzymes that share essentially an identical three dimensional (3D)-structure with E. coli
thioredoxin (Figure 2), despite their low sequence identity with the modern protein (for sequences and struc-
tures, see Figure 1 in [33]). The structures of the three proteins under study bear a proline residue at position
76 in cis conformation that is strictly conserved in thioredoxins.
Figure 3 shows chevron plots of rate constant versus denaturant concentration for E. coli thioredoxin and the
ancestral LPBCA and LBCA thioredoxins. These plots include folding and unfolding branches. We have used
guanidine, a strong denaturant, for the experiments in Figure 3 in order to achieve denaturation of the highly
stable ancestral thioredoxins. However, urea, a weaker denaturant, is used in other experiments reported in this
work but we show that the choice of denaturant does not affect our conclusions. We speciﬁcally deﬁne folding
rates in terms of the relevant kinetic phase of the major folding channel as identiﬁed by double-jump unfolding
assays (see Materials and methods for details).
As it is clear from Figure 3a, the in vitro folding of the ancestral thioredoxins is substantially faster than the
folding of their modern E. coli counterpart. Rate constants reported in this ﬁgure have been determined at 25°
C for both the modern and ancestral proteins, while high environmental temperatures (∼ 65–80°C) have been
suggested for the Archaean [36]. Experimental determinations of the temperature dependence of the rate con-
stants (Supplementary Figure S11) show that consideration of the different living temperatures of the modern
and ancient hosts does not eliminate the folding rate difference. On the contrary, the folding of the ancestral
LPBCA and LBCA thioredoxins at the proposed Archaean temperatures is actually around two orders of mag-
nitude faster than the folding of E. coli thioredoxin at the optimal living temperature (37°C) of E. coli
(Supplementary Figure S11).
For the three proteins studied, the folding rate is determined by the presence of a cis-proline at position 76,
as shown by the observation that the folding rate is considerably increased by mutating proline 76 to alanine
(compare Figure 3a,b). Of course, replacing proline at position 76 impairs activity [12], as shown by assays
based on the aggregation of insulin (Figure 3c and Supplementary Table S1) as well as assays based on the
interaction of thioredoxin with thioredoxin reductase (Supplementary Table S2). Interestingly, in the latter
assays, the activity of variants of the most ancient LBCA thioredoxin appear depressed (Supplementary
Table S2), possibly reﬂecting the consequences of coevolution between thioredoxin and thioredoxin reductase
[37]. Still, the overall picture is that replacing P76 impairs activity, which explains why proline is conserved at
position 76 in thioredoxins. Another critical point to note here is that the folding rates are similar for the three
proteins when alanine is present at position 76 and diverge when proline is present at the position. Therefore,
the slower folding of E. coli thioredoxin is attributed to mutational differences with the ancestral proteins that
aggravate the kinetic bottleneck created by proline 76. Our efforts to identify such degrading mutations are
described in the next section.
Mutational basis for the slow folding of E. coli thioredoxin as compared with
the ancestral LPBCA and LBCA thioredoxins
The sequence of E. coli thioredoxin and the ancestral thioredoxins studied here differ at ∼40–50 amino acid
positions for a protein of ∼110 residues [18,33] and, in principle, many different mutations could be respon-
sible for the slower folding of the modern protein. Still, sequence differences in the neighbourhood of pro76
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Figure 1. Thioredoxin phylogenetic tree used for ancestral sequence reconstruction [18].
(a) Schematic representation of the phylogenetic tree showing geological time. The nodes studied in this work are underlined
and are deﬁned in the text. See [18] for the deﬁnition of other nodes. (b) Bacterial section of the tree showing the evolutionary
history of the amino acid (serine or glycine) present at position 74. The ages provided for some key nodes are taken from the
Timetree of Life [32]. Numbers alongside the nodes stand for the posterior probability of the most likely residue (orange circles
for serine and green circles for glycine). Most 74S residues in the modern thioredoxins are linked to the serine residue in the
last common bacterial ancestor (LBCA node) through evolutionary trajectories that display serine conservation; these
trajectories are highlighted in orange. Most 74G residues in modern thioredoxins can be linked to previous S74G replacements
through trajectories that display glycine conservation; these trajectories are highlighted in green. The overall pattern suggests
entrenchment related to coevolution with the many macromolecular partners of thioredoxin [10,11] (see Supplementary
discussion in Supplementary material for details).
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should provide obvious candidates and one such difference stands out (Figure 2): serine is the residue at pos-
ition 74 in LBCA and LPBCA thioredoxins, while glycine is the residue at position 74 in E. coli thioredoxin.
Mutational analyses show that the S/G exchange at position 74 indeed accounts for most of the observed
folding rate difference between the modern and the ancestral proteins (Figure 4a). Replacement of the ancestral
residue at position 74 (serine) with glycine thus slows down folding in the ancestral LBCA and LPBCA thiore-
doxins, while the back-to-the-ancestor G74S in E. coli thioredoxin increases the rate of folding.
Many experiments support the robustness of our identiﬁcation of S74G as a folding-degrading mutation.
First, the folding rate enhancement obtained upon the reverse, back-to-the-ancestor G74S replacement in E.
coli thioredoxin is reproduced when the active-site disulﬁde has been reduced and also when using urea,
instead of guanidine, as denaturant (Figure 4b). In addition, E. coli thioredoxin actually has four additional
glycine residues (at positions 21, 65, 74 and 97) with respect to the ancestral LPBCA and LBCA thioredoxins
(Figure 2). However, extensive mutational studies (Supplementary Figure S10) indicate that it is only the
glycine/ancestral-state replacement at position 74 that affects the folding rate.
A mutation (S74G) that aggravated the folding problem created by the active
site cis-proline occurs in the line of descent that led to E. coli thioredoxin
As discussed above, the effect of the G/S exchange on the thioredoxin folding rate is experimentally robust.
However, while the fact that glycine is the modern residue at position 74 (the residue present in E. coli
Figure 2. 3D-structures of modern and ancestral thioredoxins.
3D-structures of E. coli thioredoxin (modern, PDB code 2TRX), and LPBCA thioredoxin (ancestral, ∼2.5 billion years, PDB code 2YJ7) and LBCA
thioredoxin (ancestral, ∼4 billion years, PDB code 4BA7) are shown. Positions with glycine residues in the modern protein are labelled. Note that the
modern and ancestral thioredoxins share the thioredoxin fold, despite low sequence identity [33]. Blow-ups of the region including the cis-pro76 are
shown below the full structures. The active-site disulﬁde bridge, the Gly/Ser residues at position 74 and residues that presumably stabilize the loop
that includes Pro76 are highlighted.
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(a) (b)
(c)
Figure 3. Folding–unfolding rates for E. coli thioredoxin and two resurrected Precambrian thioredoxins
(see Figure 1). Part 1 of 2
(a) Chevron plots (including folding and unfolding branches) of the logarithm of the rate constant versus guanidine
concentration for the ‘wild-type’ proteins that display the conserved proline at position 76. Circles and squares refer to the data
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thioredoxin) is an observable result, the identiﬁcation of serine as the ancestral residue is a statistical inference.
There could be some doubt, therefore, that the S74G replacement actually occurred in the line of descent that
led to E. coli thioredoxin. This is of particular interest given discussions from the literature [38–41] that ances-
tral sequence reconstruction can potentially be biased from uncertainties in the process. In this case, however,
(a)
(b)
Figure 4. Effect of the G/S exchange at position 74 on thioredoxin folding rate.
Chevron plots of the logarithm of folding–unfolding rate versus guanidine concentration are shown for the ‘wild-type’ forms
(closed data points) and variants (open data points). Circles and squares refer to the data obtained in the folding and unfolding
directions, respectively. (a) Comparison between the modern E. coli thioredoxin and the ancestral LBCA and LPBCA
thioredoxins. Note that glycine is the wild-type residue in E. coli thioredoxin, while serine is ‘wild-type’ in the ancestral
thioredoxins. The effects of the mutation that replaces the wild-type are highlighted with an arrow. (b) Effect of the S74G
mutation on E. coli thioredoxin folding and unfolding rates. Data obtained using urea and guanidine as denaturants are shown.
In the latter case, data obtained using thioredoxin with a reduced active-site disulﬁde are also included. Note that the panel at
the left also includes the effect of a G74A mutation (see text for details).
Figure 3. Folding–unfolding rates for E. coli thioredoxin and two resurrected Precambrian thioredoxins
(see Figure 1). Part 2 of 2
obtained in the folding and unfolding directions, respectively. (b) same as (a) except for the P76A variants of the three proteins.
(c) Plot of the time scale for folding versus in vitro reductase activity for the modern E. coli thioredoxin and the ancestral
LPBCA and LBCA thioredoxins. Values of the folding time scale are calculated as the inverse of the folding rate constant
extrapolated to zero denaturant concentration (see Materials and methods for details). Data for the ‘wild-type’ forms and the
P76A variants included in this plot are connected by arrows in order to highlight the effect of the mutation and the
function-folding trade-off: eliminating the proline at position 76 accelerates folding, but impair function. Error bars are not
shown when they are smaller than the data point.
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND).3639
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the identiﬁcation of serine as the ancestral state at position 74 is quite robust. This follows ﬁrst from the obser-
vation that serine is the consensus residue (i.e. the most frequent residue) at position 74 in modern thioredox-
ins (Figure 1b). Of course, discrepancies between consensus sequences and reconstructed ancestral sequences
do exist and may have a phenotypic impact. Yet, as we have recently discussed [42], these discrepancies are typ-
ically restricted to positions at sites with a high sequence diversity and, consequently, high evolutionary rates.
This does not appear to be the case for position 74 which is populated mainly by serine and glycine residues in
modern bacterial thioredoxins (Figure 1b). Furthermore, the Bayesian posterior probabilities for the inferred
(a)
(b)
(c)
Figure 5. Double-mutant cycle analysis on the folding rate coupling between positions 74 and 76 in thioredoxins.
Folding rates for variants of: (a) ancestral LBCA thioredoxin; (b) ancestral LPBCA thioredoxin; (c) modern E. coli thioredoxin.
Data for thioredoxin variants including P/A exchange at position 76, G/S exchange at position 74 and the combination of the
two exchanges are shown. The plots shown are meant to make visually apparent the effect of the G74S mutation is substantial
when proline is present at position 76 (plots at the left) but very low when alanine is present at position 76 (plots at the right).
Note that glycine is the wild-type residue in E. coli thioredoxin, while serine is ‘wild-type’ in the ancestral thioredoxins. Proline
is the wild-type residue at position 76 in all thioredoxins.
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND).3640
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residues in both ancestors at position 74 is 100% (Figure 1b). We have previously shown that such sites rarely,
if ever, are incorrectly inferred with such a high posterior probability [43].
Secondly, the S74G mutation decreases the folding rate of the ancestral LPBCA and LBCA thioredoxins by
about one order of magnitude and the back-to-the-inferred-ancestor mutation G74S increases the folding rate
of E. coli thioredoxin by about one order of magnitude (Figure 4 and Supplementary Figure S10). Therefore,
the effect of the S/G exchange at position 74 on the folding rate is to a large extent independent of the back-
ground sequence (modern or ancestral). This implies that the mutational effect is reasonably robust against
reconstruction uncertainties in other positions of the thioredoxin molecule.
Finally, the link between the effect of the S/G replacement at position 74 on folding kinetics and the cis-
proline at position 76 is immediately revealed by a double-mutant cycle analysis of the coupling between posi-
tions 74 and 76 on the three thioredoxins studied (Figure 5). The S/G replacement at position 74 thus strongly
affects the folding rate only when proline is at position 76 and not when pro76 has been replaced with alanine.
Clearly, the mutation S74G did occur in the line of descent that led to E. coli thioredoxin and aggravated the
folding problem created by the active site cis-proline.
Experimental study of a set of modern bacterial thioredoxins shows that
folding rates are not evolutionarily conserved
The effect of the S/G exchange at position 74 on the thioredoxin folding rate is likely related to the fact that
glycine residues have no side-chains which place little restriction on backbone dihedral angles and generate
ﬂexible links in polypeptide chains [44]. The 3D-structures of the modern and ancestral thioredoxins
studied so far (Figure 2) reveal interactions that appear to stabilize the 70–79 segment in the conformation
imposed by the cis-Pro76 (Figure 2, lower panel), namely hydrophobic contacts and a hydrogen bond
between the backbone carbonyl of residue 74 (either G or S) and Thr77. Besides stabilizing the native
protein structure with a cis-proline at position 76, these interactions should also favour local residual structures
in the high energy regions of the folding landscape that favour the cis conformer, thus promoting
correct folding. However, the ﬂexible link generated by glycine residue at position 74 should allow many
alternative conformations for the 70–79 segment to occur in the upper (high energy) regions of the folding
landscape thus slowing down folding. This interpretation is strongly supported by the fact that replacing
glycine at position 74 in E. coli thioredoxin with alanine brings about an increase in folding rate that is essen-
tially identical with that produced by the G74S (left panel in Figure 4b), thus indicating folding rate enhance-
ment is caused by the elimination of ﬂexibility at position 74, either through the G74A mutation or through
the G74S mutation.
The interpretation proposed above suggests that other amino acid replacements in the neighbourhood of
position 74 could also impact the folding rate. In particular, a visual inspection of the 3D-structures (Figure 2)
points to the residues at positions 70, 72, 74, 77 and 79 as being involved in interactions that could plausibly
modulate the stability of the 70–79 in upper regions of the folding landscape. We, therefore, used these posi-
tions to guide the selection of a set of modern bacterial thioredoxins for experimental characterization. We per-
formed a search in the NCBI Reference Sequence Database using the sequence of E. coli thioredoxin as query
and considered the ∼5000 top hits. A substantial fraction of these sequences displayed differences with E. coli
thioredoxin at positions 70, 72, 74, 77 and 79. We selected a small subset of modern thioredoxins to capture
this sequence diversity in a meaningful way (Supplementary Figure S12). That is, for some of the proteins in
the subset, most residues at positions 70, 72, 74, 77 and 79 are the same as in the ancestral LBCA or LPBCA
thioredoxins (including the presence of serine at position 74). Yet, other proteins in the subset differ at several
of the selected positions from the sequences of ancestral LBCA and LPBCA thioredoxins as well as from the
sequence of E. coli thioredoxin. In all cases, the thioredoxin selected displayed the highest sequence identity
with E. coli thioredoxin, given the amino acid residues present at positions 70, 72, 74, 77 and 79. The selected
thioredoxins show similar activities in the insulin aggregation assay (Supplementary Table S3).
Folding rates for the 14 modern proteins in the subset determined using urea as denaturant (Figure 6a) span
a ∼100-fold range, a result which is conﬁrmed by double-jump unfolding experiments that directly probe the
amount of native protein (Figure 6b, see Materials and methods for details). Of course, we cannot rule out that
a substantial part of this observed folding rate variation is due to mutational changes outside the ﬁve positions
we have used to guide the sequence selection. This, however, would not affect in the least the main implication
of the data, namely that, contrary to what has been claimed in recent literature [16,17], in vitro thioredoxin
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND).3641
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folding rates are not conserved, with some modern thioredoxins folding substantially faster and substantially
slower than E. coli thioredoxin (closed black data points in Figure 6a).
We have also included in Figure 6a rate data for the ancestral LBCA and LPBCA thioredoxins in urea solu-
tions. Clearly, while the ancestral proteins and some of the modern proteins studied fold in the approximately
minute time scale, folding of some other modern thioredoxins occurs in the much slower approximately hour
time scale.
(a)
(b)
Figure 6. Folding rates are not conserved in the thioredoxin family.
(a) Chevron plots of folding–unfolding rate constant versus urea concentration for a set of 14 modern bacterial thioredoxins.
Folding rates given correspond to the major slow phase of the ﬂuorescence kinetic proﬁles (see Materials and methods for
details). The time scale shown in the right axis is calculated as the inverse of the rate constant. For comparison, experimental
folding data for LBCA and LPBCA thioredoxins are also included. Given the high stability of the ancestral proteins, their folding
rates in urea solutions were obtained by denaturation in guanidine followed by high-dilution transfer to urea solutions, in such a
way that the ﬁnal guanidine concentration was low (∼0.1 M). Note that the folding rate data in this plot span about two orders
of magnitude. (b) Folding in 1 M urea as followed by double-jump unfolding assays, a methodology that allows a determination
of the fraction of native protein. The proﬁles shown reveal the major folding channel (see Materials and methods for details) and
are consistent with the range of folding times of the data shown in panel (a).
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND).3642
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Folding on-rates do not correlate with stability in the thioredoxin family
Unfolding rates, as given by the unfolded branches of the chevron plots in Figure 6a, already provide a useful
metric of kinetic stability [30,31]. To assess the thermodynamic stability of the modern proteins studied we
ﬁtted equilibrium proﬁles of ﬂuorescence intensity versus urea concentration on the basis of the linear extrapo-
lation model (see Material and methods for details). Fits were visually excellent (Figure 7a) and allowed us to
derive values of a known metric of thermodynamic stability: the urea concentration at which unfolding free
Figure 7. Folding on-rates do not correlate with stability in the thioredoxin family.
(a) Equilibrium proﬁles of ﬂuorescence intensity versus urea concentration for modern thioredoxins. Lines represent the best ﬁts
of a model that assumes a linear dependence of the unfolding free energy with denaturant concentration within the narrow
transition range and uses linear pre- and post-transition baselines (see Materials and methods for details and Supplementary
Table S4 for the values obtained for the ﬁtting parameters). (b and c) Plots of the logarithm of the unfolding rate constant (b)
and folding rate constant (c) versus urea midpoint concentration (the urea concentration at which the unfolding free energy is
zero). The values of the folding and unfolding rate constants are interpolated (for 1 M and 8 M urea concentration, respectively)
from the corresponding branches of the Chevron plots. Associated errors are not shown when they are smaller than the size of
the data points. Values of the correlation coefﬁcient (r) and the probability that the correlation observed occurs by chance (p)
are shown. Unfolding rates (kinetic stability) correlate with thermodynamic stability (b) but folding rates do not (c) (see the text
for details).
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND).3643
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energy is zero. These C1/2 values, as well as the m slopes that measure the urea-concentration dependence of
the unfolding free energy, are given in Supplementary Table S4 for the modern thioredoxins.
Unfolding rates do show some correlation with C1/2 values (Figure 7b). This association between kinetic and
thermodynamic stabilities is to be expected from the fact that the transition state for thioredoxin unfolding is
substantially unstructured, as we have previously noted and discussed [20,24]
Plotting the logarithm of folding rate versus C1/2 produces a scattergram (Figure 7c). This lack of correlation,
however, should not come as a surprise, as kinetic complexity and the presence of kinetic folding intermediates
should disconnect folding rates from stability. Uncoupling of kinetics and thermodynamics was already
advanced by Agard and co-workers in their seminal work on the kinetic stability of α-lytic proteases [45]. The
thioredoxin family provides an example of a phenomenon, folding rate/stability uncoupling, that is likely to be
widespread, given that the in vitro folding of many proteins, even small ones, is kinetically complex, as it has
been known for many years [46].
Conclusions
It has been recently claimed that thioredoxin folding rates as determined in vitro are evolutionarily conserved
[16,17]. This supposed conservation was furthermore taken as the ﬁrst experimental evidence of a cornerstone
of protein folding theory: the principle of minimal frustration. In very simple terms, the folding landscape was
optimized (minimally frustrated) at a very early stage and remained so over billions of years of evolutionary
history leading to folding rate conservation among modern proteins. As elaborated below in some detail,
however, this proposal is inconsistent not only with well-known principles of evolutionary theory, but also with
our current understanding of folding processes in vivo.
Proteins do not evolve in isolation because they are involved in vivo in a wide diversity of interactions [47].
In particular, protein folding within modern organisms relies on exceedingly complex intermolecular interac-
tions that guide and assist the process [4–9]. Folding in vivo occurs co-translationally, local folding events may
already take place within the ribosome exit tunnel and folding may be coupled to translation kinetics. Nascent
chains are involved in many interactions as they emerge from the ribosomal tunnel, including interactions with
the trigger factor, a protein that binds to exposed hydrophobic segments. The trigger factor is the ﬁrst of many
specialized molecules (folding chaperones) that, together with the modern ribosome, assist protein folding in
vivo. As a result of the numerous intermolecular interactions involved, the conformational space explored by a
folding chain within a modern organism in vivo may differ substantially from the conformational space that
the folding chain explores in vitro [8]. Therefore, unassisted protein folding, as probed by in vitro studies, does
not necessarily correlate with the biologically-relevant assisted folding that takes place within modern
organisms.
Of course, it is conceivable that at a very early evolutionary stage, prior to the emergence of folding assist-
ance, folding efﬁciency relied on fast folding that minimized the time scale the polypeptide chain spent in par-
tially folded states which are susceptible to aggregation and other undesirable interactions. That is, fast
unassisted folding, linked to a landscape with low (perhaps minimal) frustration, may have been required at a
primordial stage. However, once folding assistance was available, mutations that impaired unassisted folding
could be accepted. That is, as it is common in morphological evolution, a feature that it is no longer useful
undergoes evolutionary degradation. However, while degradation at the morphological level may often be visu-
ally apparent, degradation of unassisted folding can only be revealed by in vitro folding experiments, since
folding within modern cells is assisted.
Indeed, the in vitro experiments reported here are consistent with the evolutionary degradation of unassisted
folding. We have unambiguously identiﬁed a mutation that substantially slows down in vitro thioredoxin
folding and that was accepted in the line of descent that led to E. coli thioredoxin. Furthermore, we have
shown that, while resurrected Precambrian thioredoxins and some modern thioredoxins fold in vitro in the
approximately minute time scale, other modern thioredoxins approach the approximately hours time scale.
Such variation in the folding rate, indicating different degrees of degradation, should not come as surprise. As
Darwin already advanced in the ﬁrst chapter of The Descent of Man, the variability of superﬂuous features that
are not under natural selection should be a common observation in morphological studies. Indeed, such type
of variability is often illustrated with the widely variable size of the human appendix [1] while here we have
provided an example at the molecular level. It is also worth noting that folding in the approximately hours
time scale is hardly of any biological signiﬁcance and that assisted folding in vivo is likely to be much faster.
Overall, it is clear that in vitro thioredoxin folding rates are not evolutionarily conserved. As we have previously
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND).3644
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noted [20], recent claims to the contrary [16,17] are probably related to the use of destabilizing conditions
which buffer the effect of landscape ruggedness on in vitro folding experiments, as it has been known for many
years [48] and it is visually apparent in our data of Figure 6a. Note that the folding rates are roughly similar
for most thioredoxins at 4 M urea, while they diverge as the denaturant concentration becomes lower and the
solvent becomes less destabilizing. Furthermore, the very acidic pH (=2) employed in previous studies [16]
brings about extensive protonation of residues and alterations of ionic interactions that are unlikely to be
physiologically and evolutionary relevant [20].
Finally, beyond clearing up a relevant and consequential controversy in recent literature, this work has
general implications of wide interest. It points to a simple evolutionary interpretation of in vitro protein folding
as a degraded version of primordial unassisted folding and thus may contribute to clarify the much-debated
issue of the relation between protein folding in vivo and protein folding in vitro. More generally, this work pro-
vides evidence that degradation shapes evolution not only at the morphological level, but also at the level of
individual enzymes.
Abbreviations
DTNB, 5,50-dithiobis(2-nitrobenzoic acid); LPBCA, last common ancestor of the cyanobacterial, deinococcus and
thermus groups; LBCA, last bacterial common ancestor.
Authors Contributions
G.G.-A. puriﬁed the several variants of modern and ancestral thioredoxins; she also performed and analyzed the
experiments aimed at determining their folding–unfolding kinetics. V.A.R. performed bioinformatics analyses and
provided essential input for the evolutionary interpretation of the data. A.I.-P. performed preliminary experiments
that pointed to a crucial role of glycine residues. A.M.C. and M.L.R.-R. performed preliminary experiments that
pointed to the enhanced folding and unfolding rates for the ancestral thioredoxins. E.A.G. assessed the
robustness of the reconstructed ancestral states and provided essential input for the evolutionary interpretation
of the data. J.A.G. provided essential input for the structural analysis of the mutational effects on folding rates.
B.I.-M. designed and supervised the folding–unfolding kinetic experiments. B.I.-M. and J.M.S.-R. directed the
project. J.M.S.-R. provided the general evolutionary interpretation and wrote the paper. All authors read the
manuscript and provided useful comments.
Funding
This research was supported by FEDER Funds, grant BIO2015-66426-R from the Spanish Ministry of Economy
and Competitiveness ( J.M.S.-R.), grant RGP0041/2017 from the Human Frontier Science Program ( J.M.S.-R.
and E.A.G.) and National Institutes of Health 1R01AR069137 (E.A.G.), Department of Defence MURI
W911NF-16-1-0372 (E.A.G.).
Competing Interests
The authors declare that there are no competing interests associated with the manuscript.
References
1 Coyne, J.A. (2009) Why Evolution is True, Ch. 3, Oxford Univ. Press, New York, NY
2 Dawkins, R. (2009) The Greatest Show on Earth: the Evidence for Evolution, Ch. 11, Bantam Press, London, U.K.
3 Kratzer, J.T., Lanaspa, M.A., Murphy, M.N., Cicerchi, C., Graves, C.L., Tipton, P.A. et al. (2014) Evolutionary history and metabolic insights of ancient
mammalian uricases. Proc. Natl. Acad. Sci. U.S.A. 111, 3763–3768 https://doi.org/10.1073/pnas.1320393111
4 Kaiser, C.M., Goldman, D.H., Chodera, J.D., Tinoco, I. and Bustamante, C. (2011) The ribosome modulates nascent protein folding. Science 334,
1723–1727 https://doi.org/10.1126/science.1209740
5 Oh, E., Becker, A.H., Sandikci, A., Huber, D., Chaba, R., Gloge, F. et al. (2011) Selective ribosome proﬁling reveals the cotranslational chaperone action
of trigger factor in vivo. Cell 147, 1295–1308 https://doi.org/10.1016/j.cell.2011.10.044
6 Zhang, G. and Ignatova, Z. (2011) Folding at the birth of the nascent chain: coordinating translation with co-translational folding. Curr. Opin. Struct. Biol.
21, 25–31 https://doi.org/10.1016/j.sbi.2010.10.008
7 Kim, Y.E., Hipp, M.S., Bracher, A., Hayer-Hartl, M. and Hartl, F.U. (2013) Molecular chaperone functions in protein folding and proteostasis. Annu. Rev.
Biochem. 82, 323–355 https://doi.org/10.1146/annurev-biochem-060208-092442
8 Balchin, D., Hayer-Hartl, M. and Hartl, F.U. (2016) In vivo aspects of protein folding and quality control. Science 353, aac4354 https://doi.org/10.1126/
science.aac4354
9 Thommen, M., Holtkamp, W. and Rodnina, M.V. (2017) Co-traslational protein folding: progress and methods. Curr. Opin. Struct. Biol. 42, 83–89
https://doi.org/10.1016/j.sbi.2016.11.020
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND).3645
Biochemical Journal (2019) 476 3631–3647
https://doi.org/10.1042/BCJ20190739
D
ow
nloaded from
 https://portlandpress.com
/biochem
j/article-pdf/476/23/3631/862494/bcj-2019-0739.pdf by U
niversidad de G
ranada user on 13 February 2020
10 Holmgren, A. (1985) Thioredoxin. Annu. Rev. Biochem. 54, 237–271 https://doi.org/10.1146/annurev.bi.54.070185.001321
11 Kumar, J.K., Tabor, S. and Richardson, C.C. (2004) Proteomic analysis of thioredoxin-targeted proteins in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A.
101, 3759–3764 https://doi.org/10.1073/pnas.0308701101
12 Kelley, R.F. and Richards, F.M. (1987) Replacement of proline-76 with alanine eliminates the slowest kinetic phase in thioredoxin folding. Biochemistry
26, 6765–6774 https://doi.org/10.1021/bi00395a028
13 Brandts, J.F., Halvorson, H.R. and Brennan, M. (1975) Consideration of the possibility that the slow step on protein denaturation reactions is due to cis–
trans isomerism of proline residues. Biochemistry 14, 4953–4963 https://doi.org/10.1021/bi00693a026
14 Schmid, F.X. and Baldwin, R.L. (1978) Acid catalysis of the formation of the slow-folding species of RNase A: evidence that the reaction is proline
isomerization. Proc. Natl. Acad. Sci. U.S.A. 75, 4764–4768 https://doi.org/10.1073/pnas.75.10.4764
15 Schmidpeter, P.A. and Schmid, F.X. (2015) Prolyl isomerization and its catalysis in protein folding and protein function. J. Mol. Biol. 427, 1609–1631
https://doi.org/10.1016/j.jmb.2015.01.023
16 Tzul, F.O., Vasilchuk, D. and Makhatadze, G.I. (2017) Evidence for the principle of minimal frustration in the evolution of protein folding landscapes.
Proc. Natl. Acad. Sci. U.S.A. 114, E1627–E1632 https://doi.org/10.1073/pnas.1613892114
17 Tzul, F.O., Vasilchuk, D. and Makhatadze, G.I. (2017) Evidence for the evolutionary conservation of folding kinetics in the thioredoxin protein family.
Proc. Natl. Acad. Sci. U.S.A. 114, E4124 https://doi.org/10.1073/pnas.1704669114
18 Perez-Jimenez, R., Inglés-Prieto, A., Zhao, Z.M., Sanchez-Romero, I., Alegre-Cebollada, J., Kosuri, P. et al. (2011) Single-molecule paleoenzymology
probes the chemistry of resurrected enzymes. Nat. Struct. Mol. Biol. 18, 592–596 https://doi.org/10.1038/nsmb.2020
19 Romero-Romero, M.L., Risso, V.A., Martinez-Rodriguez, S., Ibarra-Molero, B. and Sanchez-Ruiz, J.M. (2016) Engineering ancestral protein hyperstability.
Biochem. J. 473, 3611–3620 https://doi.org/10.1042/BCJ20160532
20 Candel, A.M., Romero-Romero, M.L., Gamiz-Arco, G., Ibarra-Molero, B. and Sanchez-Ruiz, J.M. (2017) Fast folding and slow unfolding of a resurrected
Precambrian protein. Proc. Natl. Acad. Sci. U.S.A. 114, E4122–E4123 https://doi.org/10.1073/pnas.1703227114
21 Acevedo, O., Guzman-Casado, M., Garcia-Mira, M.M., Ibarra-Molero, B. and Sanchez-Ruiz, J.M. (2002) pH corrections in chemical denaturant solutions.
Anal. Biochem. 306, 158–161 https://doi.org/10.1006/abio.2002.5668
22 Holmgren, A. (1979) Thioredoxin catalyzes the reduction of insulin disulﬁdes by dithiothreitol and dihydrolipoamide. J. Biol. Chem. 254, 9627–9632
PMID: 385588
23 Slaby, I. and Holmgren, A. (1975) Reconstitution of Escherichia coli thioredoxin from complementing peptide fragments obtained by cleavage at
methionine-37 or arginine-73. J. Biol. Chem. 250, 1340–1347 PMID: 803502
24 Godoy-Ruiz, R., Ariza, F., Rodriguez-Larrea, D., Perez-Jimenez, R., Ibarra-Molero, B. and Sanchez-Ruiz, J.M. (2006) Natural selection for kinetic stability
is a likely origin of correlations between mutational effects on protein energetics and frequencies of amino acid occurrences in sequence alignments.
J. Mol. Biol. 362, 966–978 https://doi.org/10.1016/j.jmb.2006.07.065
25 Greene, R.F. and Pace, C.N. (1974) Urea and guanidine hydrochloride denaturation of ribonuclease, lysozyme, α-chymotrypsin, and β-lactoglobulin.
J. Biol. Chem. 249, 5388–5393 PMID: 4416801
26 Radford, S.E., Dobson, C.M. and Evans, P.A. (1992) The folding of hen lysozyme involves partially structured intermediates and multiple pathways.
Nature 358, 302–307 https://doi.org/10.1038/358302a0
27 Georgescu, R.E., Li, J.H., Goldberg, M.E., Tasayco, M.L. and Chaffotte, A.F. (1998) Proline isomerization-independent accumulation of an early
intermediate and heterogeneity of the folding pathways of a mixed α/β protein, Escherichia coli thioredoxin. Biochemistry 37, 10286–10297 https://doi.
org/10.1021/bi9805083
28 Mücke, M. and Schmid, F.X. (1994) A kinetic method to evaluate the two-state character of solvent-induced protein denaturation. Biochemistry 33,
12930–12935 https://doi.org/10.1021/bi00209a025
29 Ibarra-Molero, B. and Sanchez-Ruiz, J.M. (1997) Are there equilibrium intermediates in the urea-induced unfolding of hen-egg white lysozyme?
Biochemistry 36, 9616–9624 https://doi.org/10.1021/bi9703305
30 Sanchez-Ruiz, J.M. (2010) Protein kinetic stability. Biophys. Chem. 148, 1–15 https://doi.org/10.1016/j.bpc.2010.02.004
31 Colon, W., Church, J., Sen, J., Thibeault, J., Trasatti, H. and Xia, K. (2017) Biological roles of protein kinetic stability. Biochemistry 56, 6179–6186.
https://doi.org/10.1021/acs.biochem.7b00942
32 Hedges, S.B. and Kumar, S. (eds.) 2009. The Timetree of Life, Oxford Univ. Press, New York, NY
33 Ingles-Prieto, A., Ibarra-Molero, B., Delgado-Delgado, A., Perez-Jimenez, R., Fernandez, J.M., Gaucher, E.A. et al. (2013) Conservation of protein
structure over four billion years. Structure 21, 1690–1697 https://doi.org/10.1016/j.str.2013.06.020
34 Risso, V.A., Manssour-Triedo, F., Delgado-Delgado, A., Arco, R., Barroso-delJesus, A., Ingles-Prieto, A. et al. (2015) Mutational studies on resurrected
ancestral proteins reveal conservation of site-speciﬁc amino acid preferences throughout evolutionary history. Mol. Biol. Evol. 32, 440–455 https://doi.
org/10.1093/molbev/msu312
35 Delgado, A., Arco, R., Ibarra-Molero, B. and Sanchez-Ruiz, J.M. (2017) Using resurrected ancestral proviral proteins to engineer virus resistance. Cell
Rep. 19, 1247–1256 https://doi.org/10.1016/j.celrep.2017.04.037
36 Garcia, A.K., Schopf, J.W., Yokobory, S., Akanuma, A. and Yamagishi, A. (2017) Reconstructed ancestral enzymes suggest long-term cooling of Earth’s
photic zone since the Archean. Proc. Natl. Acad. Sci. U.S.A 114, 4619–4624 https://doi.org/10.1073/pnas.1702729114
37 Napolitano, S., Reber, R.J., Rubini, M. and Glockshuber, R. (2019) Functional analyses of ancestral thioredoxins provide insight into their evolutionary
history. J. Biol. Chem. 294, 14105–14118 https://doi.org/10.1074/jbc.RA119.009718
38 Williams, P.D., Pollock, D.D., Blackburne, B.P. and Goldstein, R.A. (2006) Assessing the accuracy of ancestral protein reconstruction methods. PLoS
Comput. Biol. 2, e69 https://doi.org/10.1371/journal.pcbi.0020069
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